Andreas Wicki
Chief Executive Officer presso HBM HEALTHCARE INVESTMENTS AG
Patrimonio netto: 12 M $ in data 31/03/2024
Profilo
Andreas Wicki is currently the Chief Executive Officer at HBM Partners AG since 2004.
He is also the Chief Executive Officer at HBM Healthcare Investments AG since 2001 and the Chief Executive Officer & Director at HBM Healthcare Investments (Cayman) Ltd.
since 2001.
Additionally, he holds the position of Chief Executive Officer at HBM Partners AG (Investment Management) since 2004.
Dr. Wicki serves as a Director at HBM BioVentures (Cayman) Ltd.
since 2001 and as an Independent Director at Pacira Biosciences, Inc. since 2006.
He is also a Director at HBM Biocapital Ltd.
since 2004.
Dr. Wicki holds director positions at Buchler GmbH, MDS Pharma Services Switzerland AG, HBM BioPharma India Ltd., Vitaeris, Inc., Harmony Biosciences Holdings, Inc., and Harmony Biosciences LLC.
In his former positions, Dr. Wicki served as the Chief Executive Officer & Co-Owner at Clinserve Laboratories and Anawa Laboratorien AG from 1990 to 1998.
He was the Deputy Chairman at Basilea Pharmaceutica AG from 2000 to 2009 and a Director at Pharmaswiss SA from 2007 to 2011.
Dr. Wicki also served as an Independent Director at Viela Bio, Inc. from 2019 to 2022.
He held the position of Senior VP-European Analytical Operations at Nordion (Canada), Inc. and MDS (US), Inc. from 1998 to 2001.
Dr. Wicki obtained his graduate and doctorate degrees from the University of Bern in 1986.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2023 | 54 182 ( 0.78% ) | 12 M $ | 31/03/2024 |
Posizioni attive di Andreas Wicki
| Società | Posizione | Inizio |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Director/Board Member | 01/12/2006 |
| HBM HEALTHCARE INVESTMENTS AG | Chief Executive Officer | 20/02/2012 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director/Board Member | 01/09/2017 |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Chief Executive Officer | 02/01/2004 |
HBM Biocapital Ltd.
 HBM Biocapital Ltd. Financial ConglomeratesFinance Part of HBM Partners AG, HBM Biocapital Ltd. is a Caymanian company that provides investment services. The private company is based in George Town, Cayman Islands. | Director/Board Member | 01/01/2004 |
Buchler GmbH
 Buchler GmbH Chemicals: SpecialtyProcess Industries Buchler GmbH engages in the manufacture of pure enantiomers for the pharmaceutical, chemical, and beverage industries. Its product portfolio includes Cinchona alkaloids, quinuclidines, and Quinic acid. The company was founded in 1858 and is headquartered in Braunschweig, Germany. | Director/Board Member | - |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Director/Board Member | - |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Director/Board Member | - |
HBM Healthcare Investments (Cayman) Ltd.
 HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Chief Executive Officer | 01/01/2001 |
| ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Andreas Wicki
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Andreas Wicki
| University of Bern | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PACIRA BIOSCIENCES, INC. | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
| Aziende private | 17 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Finance |
HBM BioVentures (Cayman) Ltd.
 HBM BioVentures (Cayman) Ltd. Financial ConglomeratesFinance Part of HBM Partners AG, HBM BioVentures (Cayman) Ltd. is an acquisition vehicle. The private company is based in George Town, Cayman Islands. | Finance |
Clinserve Laboratories
 Clinserve Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Clinserve Laboratories is a German company that provides medical research services. The company is based in Hamburg, Germany. Clinserve Laboratories was acquired by Phoenix International Life Sciences, Inc., part of Sotera Health Co. from May 22, 2000 on November 06, 1998 for $2.19 million. | Commercial Services |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment ManagersFinance HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds. | Finance |
HBM Biocapital Ltd.
HBM Biocapital Ltd. Financial ConglomeratesFinance Part of HBM Partners AG, HBM Biocapital Ltd. is a Caymanian company that provides investment services. The private company is based in George Town, Cayman Islands. | Finance |
PharmaSwiss SA
 PharmaSwiss SA Medical DistributorsDistribution Services PharmaSwiss SA engages in the provision of healthcare solutions. It also offers consulting services. The company was founded on January 24, 2000 and is headquartered in Zug, Switzerland. | Distribution Services |
Buchler GmbH
Buchler GmbH Chemicals: SpecialtyProcess Industries Buchler GmbH engages in the manufacture of pure enantiomers for the pharmaceutical, chemical, and beverage industries. Its product portfolio includes Cinchona alkaloids, quinuclidines, and Quinic acid. The company was founded in 1858 and is headquartered in Braunschweig, Germany. | Process Industries |
| MDS Pharma Services Switzerland AG | |
HBM BioPharma India Ltd.
 HBM BioPharma India Ltd. Pharmaceuticals: MajorHealth Technology HBM BioPharma India Ltd. is an Indian company that manufactures pharmaceuticals. | Health Technology |
| Anawa Laboratorien AG | |
| MDS (US), Inc. | Health Technology |
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Health Services |
HBM Partners AG (Investment Management)
 HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Finance |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. BiotechnologyHealth Technology Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD. | Health Technology |
- Borsa valori
- Insiders
- Andreas Wicki
